BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Linke-Serinsöz E, Fend F, Quintanilla-Martinez L. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point. Semin Diagn Pathol 2017;34:352-63. [PMID: 28506687 DOI: 10.1053/j.semdp.2017.04.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Atallah-Yunes SA, Murphy DJ, Noy A. HIV-associated Burkitt lymphoma. Lancet Haematol 2020;7:e594-600. [PMID: 32735838 DOI: 10.1016/S2352-3026(20)30126-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
2 Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Estimating the global burden of Epstein-Barr virus-related cancers. J Cancer Res Clin Oncol 2021. [PMID: 34705104 DOI: 10.1007/s00432-021-03824-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wu J, Miao Y, Qian C, Tao P, Wang X, Dong X, Li X, Lou J, Liang J, Xu W, Li J, Min H. Clinical characteristics and outcomes in HIV-associated diffuse large B-cell lymphoma in China: A retrospective single-center study. J Cancer 2021;12:2903-11. [PMID: 33854591 DOI: 10.7150/jca.51027] [Reference Citation Analysis]
4 Pan S, Yu T, Wang Y, Lu R, Wang H, Xie Y, Feng X. Identification of a Torque Teno Mini Virus (TTMV) in Hodgkin's Lymphoma Patients. Front Microbiol 2018;9:1680. [PMID: 30093892 DOI: 10.3389/fmicb.2018.01680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Porpaczy E, Tripolt S, Hoelbl-Kovacic A, Gisslinger B, Bago-Horvath Z, Casanova-Hevia E, Clappier E, Decker T, Fajmann S, Fux DA, Greiner G, Gueltekin S, Heller G, Herkner H, Hoermann G, Kiladjian JJ, Kolbe T, Kornauth C, Krauth MT, Kralovics R, Muellauer L, Mueller M, Prchal-Murphy M, Putz EM, Raffoux E, Schiefer AI, Schmetterer K, Schneckenleithner C, Simonitsch-Klupp I, Skrabs C, Sperr WR, Staber PB, Strobl B, Valent P, Jaeger U, Gisslinger H, Sexl V. Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy. Blood 2018;132:694-706. [PMID: 29907599 DOI: 10.1182/blood-2017-10-810739] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 19.0] [Reference Citation Analysis]
6 Wang Y, Yang J, Wen Y. Lessons from Epstein-Barr virus DNA detection in cerebrospinal fluid as a diagnostic tool for EBV-induced central nervous system dysfunction among HIV-positive patients. Biomed Pharmacother 2022;145:112392. [PMID: 34781140 DOI: 10.1016/j.biopha.2021.112392] [Reference Citation Analysis]
7 Montgomery ND, Randall C, Painschab M, Seguin R, Kaimila B, Kasonkanji E, Zuze T, Krysiak R, Sanders MK, Elliott A, Miller MB, Kampani C, Chimzimu F, Mulenga M, Damania B, Tomoka T, Fedoriw Y, Dittmer DP, Gopal S. High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi. Cancer Med 2020;9:552-61. [PMID: 31782984 DOI: 10.1002/cam4.2710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Meer S, Perner Y, McAlpine ED, Willem P. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area. Histopathology 2020;76:212-21. [PMID: 31361906 DOI: 10.1111/his.13964] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
9 de Carvalho PS, Leal FE, Soares MA. Clinical and Molecular Properties of Human Immunodeficiency Virus-Related Diffuse Large B-Cell Lymphoma. Front Oncol 2021;11:675353. [PMID: 33996608 DOI: 10.3389/fonc.2021.675353] [Reference Citation Analysis]
10 Shi L, Yu L, Zhong D, Gu C, Lv L, Zeng X, Yao X, Li L, Liu S. TMC120 displayed potent cytotoxic effect on human cervical carcinoma through enhancing the polymerization of microtubules. AIDS 2018;32:1107-14. [PMID: 29596107 DOI: 10.1097/QAD.0000000000001808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Sanguedolce F, Zanelli M, Zizzo M, Martino G, Rossi C, Parente P, Ascani S. Clinical, pathological and molecular features of plasmablastic lymphoma arising in the gastrointestinal tract: A review and reappraisal. Pathol Res Pract 2020;216:152973. [PMID: 32370987 DOI: 10.1016/j.prp.2020.152973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Rezk SA, Weiss LM. EBV-Associated Lymphoproliferative Disorders: Update in Classification. Surg Pathol Clin 2019;12:745-70. [PMID: 31352986 DOI: 10.1016/j.path.2019.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Biggi AFB, Elgui de Oliveira D. The Epstein-Barr Virus Hacks Immune Checkpoints: Evidence and Consequences for Lymphoproliferative Disorders and Cancers. Biomolecules 2022;12:397. [DOI: 10.3390/biom12030397] [Reference Citation Analysis]
14 Granai M, Ambrosio MR, Akarca A, Mundo L, Vergoni F, Santi R, Mancini V, di Stefano G, Amato T, Bellan C, Puccini B, Sorrentino E, Naresh KN, Leoncini L, Marafioti T, Lazzi S. Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature. Haematologica 2019;104:e269-73. [PMID: 30846502 DOI: 10.3324/haematol.2018.215053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
15 Gutiérrez S, Barranco G, Ramirez A, Sánchez S, Alatorre P, Cevallos J, Lome C. Lymphomatoid granulomatosis in one patient with newly diagnosed HIV infection and Kaposi's sarcoma: a case report and literature review. J Hematop 2021;:1-5. [PMID: 33777257 DOI: 10.1007/s12308-021-00447-7] [Reference Citation Analysis]
16 Marques-Piubelli ML, Salas YI, Pachas C, Becker-Hecker R, Vega F, Miranda RN. Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review. Pathology. 2020;52:40-52. [PMID: 31706670 DOI: 10.1016/j.pathol.2019.09.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
17 Granai M, Mundo L, Akarca AU, Siciliano MC, Rizvi H, Mancini V, Onyango N, Nyagol J, Abinya NO, Maha I, Margielewska S, Wi W, Bibas M, Piccaluga PP, Quintanilla-Martinez L, Fend F, Lazzi S, Leoncini L, Marafioti T. Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program. Infect Agent Cancer 2020;15:28. [PMID: 32391073 DOI: 10.1186/s13027-020-00292-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
18 Tong Y, Xiang Y, Li B, Bao S, Zhou Y, Yuan W, Ling Y, Hao D, Zhu H, Sun Z. Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma. Med Sci Monit 2018;24:7015-22. [PMID: 30279407 DOI: 10.12659/MSM.908813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Grewal R, Irimie A, Naidoo N, Mohamed N, Petrushev B, Chetty M, Tomuleasa C, Abayomi EA. Hodgkin's lymphoma and its association with EBV and HIV infection. Crit Rev Clin Lab Sci 2018;55:102-14. [PMID: 29316828 DOI: 10.1080/10408363.2017.1422692] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
20 Rezk SA, Zhao X, Weiss LM. Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update. Hum Pathol 2018;79:18-41. [PMID: 29885408 DOI: 10.1016/j.humpath.2018.05.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
21 Verdu-Bou M, Tapia G, Hernandez-Rodriguez A, Navarro JT. Clinical and Therapeutic Implications of Epstein-Barr Virus in HIV-Related Lymphomas. Cancers (Basel) 2021;13:5534. [PMID: 34771697 DOI: 10.3390/cancers13215534] [Reference Citation Analysis]
22 Okello CD, Niyonzima N, Ferraresso M, Kadhumbula S, Ddungu H, Tarlock K, Balagadde-Kambugu J, Omoding A, Ngendahayo L, Karagu A, Mwaiselage J, Harlan JM, Uldrick TS, Turner SD, Orem J. Haematological malignancies in sub-Saharan Africa: east Africa as an example for improving care. Lancet Haematol 2021;8:e756-69. [PMID: 34481552 DOI: 10.1016/S2352-3026(21)00198-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Navarro JT, Moltó J, Tapia G, Ribera JM. Hodgkin Lymphoma in People Living with HIV. Cancers (Basel) 2021;13:4366. [PMID: 34503176 DOI: 10.3390/cancers13174366] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Vera G, Cordova P, Sepulveda G, Benavides T, Astorga F, Gonzalez W. Plasmablastic lymphoma as a manifestation of the human immunodeficiency virus: Case report. J Clin Exp Dent 2020;12:e429-32. [PMID: 32382394 DOI: 10.4317/jced.56482] [Reference Citation Analysis]
25 Sukswai N, Lyapichev K, Khoury JD, Medeiros LJ. Diffuse large B-cell lymphoma variants: an update. Pathology 2020;52:53-67. [PMID: 31735345 DOI: 10.1016/j.pathol.2019.08.013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
26 Dojcinov SD, Fend F, Quintanilla-Martinez L. EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts. Pathogens 2018;7:E28. [PMID: 29518976 DOI: 10.3390/pathogens7010028] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
27 Lang F, Pei Y, Lamplugh ZL, Robertson ES. Molecular Biology of EBV in Relationship to HIV/AIDS-Associated Oncogenesis. Cancer Treat Res 2019;177:81-103. [PMID: 30523622 DOI: 10.1007/978-3-030-03502-0_4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Yoon S, Ryu KH, Baek HJ, An HJ, Joo YH. Epstein-Barr virus-positive diffuse large B-cell lymphoma with human immunodeficiency virus mimicking complicated frontal sinusitis: A case report. World J Clin Cases 2021; 9(7): 1654-1660 [PMID: 33728309 DOI: 10.12998/wjcc.v9.i7.1654] [Reference Citation Analysis]
29 Ramburan A, Kriel R, Govender D. Plasmablastic lymphomas show restricted EBV latency profile and MYC gene aberrations. Leuk Lymphoma 2021;:1-7. [PMID: 34612761 DOI: 10.1080/10428194.2021.1986218] [Reference Citation Analysis]
30 Sánchez-Ponce Y, Fuentes-Pananá EM. The Role of Coinfections in the EBV-Host Broken Equilibrium. Viruses 2021;13:1399. [PMID: 34372605 DOI: 10.3390/v13071399] [Reference Citation Analysis]
31 Chua TH, Punjabi LS, Khor LY. Tissue Pathogens and Cancers: A Review of Commonly Seen Manifestations in Histo- and Cytopathology. Pathogens 2021;10:1410. [PMID: 34832566 DOI: 10.3390/pathogens10111410] [Reference Citation Analysis]